AnGes Inc 4563.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
946.00quote price arrow down-24.00 (-2.47%)
Volume
2,155,300
52 week range
711.00 - 2,492.00

...

Loading . . .
  • Open962.00
  • Day High966.00
  • Day Low945.00
  • Prev Close970.00
  • 52 Week High2,492.00
  • 52 Week High Date06/26/20
  • 52 Week Low711.00
  • 52 Week Low Date04/13/20

Key Stats

  • Market Cap1,209.75M
  • Shares Out133.06M
  • 10 Day Average Volume2.07M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-24.02

KEY STATS

  • Open962.00
  • Day High966.00
  • Day Low945.00
  • Prev Close970.00
  • 52 Week High2,492.00
  • 52 Week High Date06/26/20
  • 52 Week Low711.00
  • 52 Week Low Date04/13/20
  • Market Cap1,209.75M
  • Shares Out133.06M
  • 10 Day Average Volume2.07M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-24.02

RATIOS/PROFITABILITY

  • EPS (TTM)-71.40
  • P/E (TTM)-13.25
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From AnGes Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to...
Ei Yamada
President
Address
7-7-15 Saito-asagi
Saito Bio-Incubator 4 Fl.
Ibaraki-shi, OSK
567-0085
Japan